Impact of SGLT2 Inhibitors on Cardiovascular Risk Scores, Metabolic Parameters, and Laboratory Profiles in Type 2 Diabetes.

Life (Basel) · 2025 · PMC12112772 · PMID 40430150

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp = 0.001actually significant

Patients demonstrated a significant reduction in high-risk categorization (β = −0.777, p < 0.001) and low-risk categorization (β = −0.597, p = 0.007), with the overall effect of measurement time being highly significant (Wald χ 2 = 10.624, p = 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.